Cognizant Technology Solutions (CTSH)
(Delayed Data from NSDQ)
$76.89 USD
-0.31 (-0.40%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $76.88 -0.01 (-0.01%) 5:28 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$76.89 USD
-0.31 (-0.40%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $76.88 -0.01 (-0.01%) 5:28 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Zacks News
Analysts Estimate Cognizant (CTSH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Value Investors Consider Cognizant Technology (CTSH)?
by Zacks Equity Research
Cognizant Technology (CTSH) stock may be a good choice for value-oriented investors right now from multiple angles.
CTSH or TYL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTSH vs. TYL: Which Stock Is the Better Value Option?
Outlook for Business-Software Services Stocks Appears Bright
by Madhura Bhattacharyya
The Zacks Business-Software Services industry is gaining traction from a strong demand environment for multi cloud-enabled software solutions.
Why Is Cognizant (CTSH) Down 0.9% Since Last Earnings Report?
by Zacks Equity Research
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cognizant Acquires Meritsoft, Strengthens SaaS Portfolio
by Zacks Equity Research
Cognizant's (CTSH) acquisition of Meritsoft not only strengthens the former's software-as-a-Service (SaaS) portfolio but also expands its footprint among financial institutions.
Cognizant (CTSH) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter 2018 results benefit from growth across all four domains.
Cognizant (CTSH) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 7.62% and 0.37%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) Q4 Earnings: Is a Disappointment in Store?
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter results are likely to be hurt by banking weakness despite gains from solid domain expertise and acquisitions that are adding new customers.
Cognizant (CTSH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cognizant (CTSH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Cognizant (CTSH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Cognizant (CTSH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Accenture Rides on Buyouts & Cloud, Pricing Pressure Rife
by Zacks Equity Research
While acquisitions increase Accenture's (ACN) revenue opportunities along with business mix and profitability, stiff completion leads to pricing pressure.
Accenture Boosts Financial Services With Orbium Buyout
by Zacks Equity Research
The acquisition is likely to boost Accenture's (ACN) Financial Services segment and enhance its global presence in terms of Avaloq execution.
Why Is Cognizant (CTSH) Up 2.5% Since Last Earnings Report?
by Zacks Equity Research
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Accenture Completes Kaplan Buyout, Boosts Nordics Presence
by Zacks Equity Research
The acquisition of Kaplan is a part of Accenture (ACN) Interactive's bid to boost Nordics presence.
The Zacks Analyst Blog Highlights: Walmart, Cognizant, Vale, Church & Dwight and Ball
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, Cognizant, Vale, Church & Dwight and Ball
Top Stock Reports for Walmart, Cognizant & Vale
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Walmart (WMT), Cognizant (CTSH) and Vale (VALE).
Cognizant (CTSH) Beats on Q3 Earnings, Revenues Increase Y/Y
by Zacks Equity Research
Cognizant's (CTSH) third-quarter 2018 results benefit from growth across all four domains.
Cognizant (CTSH) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 5.31% and -0.03%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Cognizant (CTSH) in Q3 Earnings?
by Zacks Equity Research
Cognizant's (CTSH) third-quarter results are likely to benefit from domain expertise and acquisitions that are adding new customers.
Cognizant (CTSH) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TransUnion Inks Deal to Buy Rubixis, Boosts Healthcare Suite
by Zacks Equity Research
The deal to acquire Rubixis is expected to boost TransUnion (TRU) Healthcare's portfolio.
Cognizant Set to Acquire Digital Engineering Firm Softvision
by Zacks Equity Research
Cognizant's (CTSH) acquisition of Softvision is likely to fortify its hold in areas like AI, VR, IoT and human science.
Accenture (ACN) Boosts Industry X.0 Suite With Two Buyouts
by Zacks Equity Research
The recently announced acquisitions are likely to boost Accenture's (ACN) presence in North America as well as its Industry X.0's potential in outlining innovative products and services.
Cognizant (CTSH) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cognizant (CTSH) reports better-than-expected bottom-line figure in second-quarter 2018. Revenues come within the guided range.